SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-022852
Filing Date
2023-05-04
Accepted
2023-05-04 07:30:22
Documents
14
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20052467_8k.htm   iXBRL 8-K 27684
2 EXHIBIT 99.1 brhc20052467_ex99-1.htm EX-99.1 209449
6 image00003.jpg GRAPHIC 2416
  Complete submission text file 0001140361-23-022852.txt   401469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA insm-20230504.xsd EX-101.SCH 3859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20230504_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20230504_pre.xml EX-101.PRE 16040
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc20052467_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 23886479
SIC: 2834 Pharmaceutical Preparations